4.5 Article

Divergent intracellular pathways regulate interleukin-1β-induced miR-146a and miR-146b expression and chemokine release in human alveolar epithelial cells

Journal

FEBS LETTERS
Volume 583, Issue 20, Pages 3349-3355

Publisher

WILEY
DOI: 10.1016/j.febslet.2009.09.038

Keywords

MicroRNA; Inflammation; Epithelium; Innate immune response; Interleukin-1 beta; miR-146

Funding

  1. National Heart and Lung Institute PhD Studentship
  2. Wellcome Trust [076111]
  3. Asthma UK [07/015]
  4. National Institute of Health Research
  5. Asthma UK [07/015] Funding Source: researchfish

Ask authors/readers for more resources

We have previously reported that IL-beta-induced miR-146a and miR-146b expression negatively regulates IL-8 and RANTES release in human alveolar A549 epithelial cells. To determine the intracellular pathways that regulate this response, we demonstrate IL-1 beta-induced activation of the nuclear factor (NF)-kappa B, extracellular regulated kinase (ERK)-1/2, c-jun N-terminal kinase (JNK)-1/2 and p38 mitogen activated kinase (MAP) kinase pathways. Subsequent pharmacological studies show that IL-1b-induced miR-146a, IL-8 and RANTES production was regulated via NF-kappa B and JNK-1/2 whilst miR-146b expression was mediated via MEK-1/2 and JNK-1/2. These divergent intracellular pathways likely explain the differential expression and biological action of the miR-146 isoforms. Crown Copyright (C) 2009 Published by Elsevier B. V. on behalf of Federation of European Biochemical society. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available